[1]
[2] 《曲美他嗪治疗冠心病合并左心功能不全患者的疗效研究》[J].中华心血管病杂志,2005(9).
[2] Antman EM,Anbe DT,Armstrong ER,et al.ACC/AHAguidelines for the management of patients with ST-elevationmyocardial infarction[J].Circulation,2004,110(5):588-636.
[4]
[3] Fox KA,Poole-Wilson PA,Henderson RA,et al.Interventionalversus conservative treatment for patients with unstable angina ornon-ST elevation myocardial infarction[J].Lancet,2002,360(9335):743-751.
[6]
[4] Boden WE,O'Rourke RA,Teo KK,et al.COURAGE TrialResearch Group.Optimal medical therapy with or without PCI forstable coronary disease[J].N Engl J Med,2007,356(15):1503-1516.
[8]
[5] Yellon DM,Hausenloy D.Myocardial reperfusion injury[J].NEngl J Med,2007,357(11):1121-1135.
[10]
[6] Kober G,Buck T,Sievert H,et al.Myocardial protection duringpercutaneous transluminal coronary angioplasty;Effects oftrimetazidine[J].Euro Heart J,1992,13(8):1109-1115.
[12]
[7] Aussedet J,Ray A,Kay L,et al.Improvement of long-termpreservation of isolated tat heart:beneficial effect of theantiischemic agent trimetazidine[J].J Cardiovasc Pharmacol,1993,21(6):128-135.
[14]
[8] Stanley WC,Lopaschuk GD,Hall JL,et al.Regulation ofmyocardial carbohydrate metabolism under normal and ischaemecconditions.Potential for pharmacological interventions[J].Cardiovasc Res,1997,33(2):243-257.
[16]
[9] Desideri A,Celegon L.Metabolic management of ischemic heartdisease:clinical data with trimetazidine[J].Am Cardiol,1998,82(5A):50K-53K.＜br＞
[10] Guarnieri C,Muscari C.Effect of trimetazidine on mitochondrialfunction and oxidative damage during reperfusion of ischemichypertrophied rat myocardium[J].Pharmacology,1993,46(6):324-331.
[19]
[11] Williams FM,Tanda K,Kus M,et al.Trimetazidine inhibitsneutrophil accumulation after myocardial ischemia andreperfusion in rabbits[J].J Cardiovasc Pharmacol,1993,22(6):828-833.
[21]
[12] Bertomeu Gonzalez V,Bouzas Mosquera A,Kaski JC.Role oftrimetazidine in management of ischemic cardiomyopathy[J].AmJ Cardiol,2006,98(5A):19-24.
[23]
[13] Polonski L,Dec I,Wojnar R,et al.Trimetazidine limits the effectsof myocardial ischaemia during percutaneous coronary angioplasty[J].Curr Medi Res Opin,2002,18(7):389-396.
[25]
[14] Bonello L,Sbragia P,Amabile N,et al.Protective effect of anacute oral loading dose of Trimetazidine on myocardial injuryfollowing percutaneous coronary intervention[J].Heart,2007,93(6):703-707.
[27]
[15] Labrou A,Ciannoglou G,Zioutas D,et al.Trimetazidineadministration minimizes myocardial damage and improves leftventricular function after percutaneous coronary intervention[J].Am J Cardiovasc Drugs,2007,7(2):143-150.